- Home
- MQT vs SOPH Comparison
MQT vs SOPH Comparison
Compare MQT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQT
- SOPH
- Stock Information
- Founded
- MQT 1992
- SOPH 2011
- Country
- MQT United States
- SOPH Switzerland
- Employees
- MQT N/A
- SOPH N/A
- Industry
- MQT Investment Bankers/Brokers/Service
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MQT Finance
- SOPH Health Care
- Exchange
- MQT Nasdaq
- SOPH Nasdaq
- Market Cap
- MQT 235.7M
- SOPH 247.0M
- IPO Year
- MQT N/A
- SOPH 2021
- Fundamental
- Price
- MQT $10.46
- SOPH $3.38
- Analyst Decision
- MQT
- SOPH Strong Buy
- Analyst Count
- MQT 0
- SOPH 3
- Target Price
- MQT N/A
- SOPH $7.00
- AVG Volume (30 Days)
- MQT 52.5K
- SOPH 23.0K
- Earning Date
- MQT 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- MQT 4.60%
- SOPH N/A
- EPS Growth
- MQT N/A
- SOPH N/A
- EPS
- MQT N/A
- SOPH N/A
- Revenue
- MQT N/A
- SOPH $64,488,000.00
- Revenue This Year
- MQT N/A
- SOPH $7.37
- Revenue Next Year
- MQT N/A
- SOPH $20.71
- P/E Ratio
- MQT N/A
- SOPH N/A
- Revenue Growth
- MQT N/A
- SOPH 9.85
- 52 Week Low
- MQT $8.59
- SOPH $2.70
- 52 Week High
- MQT $10.67
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- MQT 47.05
- SOPH 43.99
- Support Level
- MQT $10.27
- SOPH $3.31
- Resistance Level
- MQT $10.50
- SOPH $3.93
- Average True Range (ATR)
- MQT 0.11
- SOPH 0.23
- MACD
- MQT 0.00
- SOPH 0.01
- Stochastic Oscillator
- MQT 45.83
- SOPH 20.42
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.